Clinical Trial Update: Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of BLX-028914 in subjects with allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• BLX-028914

Snippet

Sponsor: Dart NeuroScience, LLC | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED